Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Italy

Marie Skłodowska-Curie Action · Running

OSTEONET In vitro 3D cell models of healthy and OSTEOpathological ageing bone tissue for implantation and drug testing in a multidisciplinary NETwork

Coordinator
Universita Della Calabria, Italy
Runs
1 January 2023 to 31 December 2027
Status
Running
EU funding
€1.5m
Total cost
—
Partners
18 organisations in 10 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101086329

What the project is doing

In the project's own words, from its summary on CORDIS.

OSTEONET aims to (i) build a multidisciplinary research network involving experts of technical and medical disciplines to merge their expertise and exploit possible synergies for the development of reliable and sustainable 3D in vitro cell models of healthy and aged bone tissue and (ii) train a cohort of scientists and technologists in exploiting the model features to increase knowledge on the effects of ageing on bone biology and mechanobiology, and on bone response to drugs, to leverage the use of 3D cell models in clinics and basic/industrial research labs.

Bone ageing reduces the quality of life of the elderly and puts social and economic burden on society. Ageing bones fail more easily when challenged mechanically or with toxicants or pollutants, and respond differently to drugs than healthy bone. To personalize therapies and enable better preventive care for the elderly it is essential to develop reliable and sustainable in vitro models of aged bone tissue alternative to animal tests which often fail to capture human-specific features.

Several scientific studies support the idea that in vitro models of bone tissue are an outstanding resource for (i) the comprehension of bone physiology, (ii) a better understanding of pathological pathways in most bone dysfunctions, (iii) testing new or repurposed drugs for bone treatment before preclinical trials with animal models. The networking activities planned in OSTEONET will unravel and share knowledge on the mechanisms driving the information transfer from the biochemical and biomechanical levels, which drive osteosynthesis and osseointegration, to the cascade of molecular and cellular events emerging as an elaborated and physiological bone, and on the mechanisms of the different response of healthy and aged bone tissue to mechano-biological stimuli and drugs.

Who is involved

OrganisationCityCountryRole
Universita Della CalabriaArcavacata Di RendeItalyCoordinator
Lithoz GmbHWienAustriaParticipant
Medizinische Universitaet WienWienAustriaParticipant
Universiteit GentGentBelgiumParticipant
Technische Hochschule MittelhessenGiessenGermanyParticipant
Athina-Erevnitiko Kentro Kainotomias Stis Technologies Tis Pliroforias, Ton Epikoinonion Kai Tis GnosisMaroussiGreeceParticipant
Efiis Sistemiki Viologia Monoprosopi IkePatraGreeceParticipant
Universitat Politecnica De ValenciaValenciaSpainParticipant
ElvesysParisFranceParticipant
Microfluidics Innovation CenterParisFranceParticipant
Tel Aviv UniversityTel AvivIsraelParticipant
7hc Societa a Responsabilita LimitataRomaItalyParticipant
Cellex SRLRomaItalyParticipant
Consorzio Di Ricerca HypatiaGrottaferrataItalyParticipant
Universita Degli Studi Di TorinoTorinoItalyParticipant
Universitetet I BergenBergenNorwayParticipant
Aifactory Sp ZooGdańskPolandParticipant
Ctadventure Spólka Z Ograniczona OdpowiedzialnosciaGdanskPolandParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI